Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10040789HBVENSG00000198431.18protein_codingTXNRD1NoNo7296Q16881
TVIS30018385HIVENSG00000198431.18protein_codingTXNRD1NoNo7296Q16881
TVIS30083932HIVENSG00000198431.18protein_codingTXNRD1NoNo7296Q16881
TVIS30078066HIVENSG00000198431.18protein_codingTXNRD1NoNo7296Q16881
TVIS30075926HIVENSG00000198431.18protein_codingTXNRD1NoNo7296Q16881
TVIS20022665HPVENSG00000198431.18protein_codingTXNRD1NoNo7296Q16881
TVIS44033965HTLV-1ENSG00000198431.18protein_codingTXNRD1NoNo7296Q16881
TCGA Plot Options
Drug Information
GeneTXNRD1
DrugBank IDDB01169
Drug NameArsenic trioxide
Target IDBE0001979
UniProt IDQ16881
Regulation Typeinhibitor
PubMed IDs17640917
CitationsLu J, Chew EH, Holmgren A: Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12288-93. Epub 2007 Jul 18.
GroupsApproved; Investigational
Direct ClassificationMetalloid oxides
SMILESO=[As]O[As]=O
Pathways
PharmGKBPA448486
ChEMBLCHEMBL1200978